You are using an outdated browser. Please upgrade your browser to improve your experience.

substance withdrawal syndrome

Disease Summary
Associated Targets (79)
Tclin

32

Tbio

27

Tchem

20


Mondo Description A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions.
Disease Ontology Description A substance-related disorder that occurs upon the abrupt discontinuation/separation or a decrease in dosage of the intake of medications, recreational drugs, and alcohol.
Mondo Term and Equivalent IDs
MONDO:0005567:  substance withdrawal syndrome
EFO:0005800: 
ICD9:292.0: 
MESH:D013375: 
NCIT:C35046: 
SCTID:363101005: 
UMLS:C0152128: